-
Je něco špatně v tomto záznamu ?
Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells in Pig Transgenic Model Expressing Human Mutant Huntingtin
P. Smatlikova, S. Juhas, J. Juhasova, T. Suchy, M. Hubalek Kalbacova, Z. Ellederova, J. Motlik, J. Klima,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV15-25813A
MZ0
CEP - Centrální evidence projektů
PubMed
30584151
DOI
10.3233/jhd-180303
Knihovny.cz E-zdroje
- MeSH
- adipogeneze * MeSH
- buňky kostní dřeně cytologie MeSH
- geneticky modifikovaná zvířata genetika MeSH
- Huntingtonova nemoc genetika patologie MeSH
- kultivované buňky MeSH
- lidé MeSH
- mezenchymální kmenové buňky cytologie MeSH
- prasata MeSH
- transkripční faktory genetika MeSH
- tukové buňky cytologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Although the highest expression of mutant huntingtin (mtHtt) was observed in the brain, its negative effects were also apparent in other tissues. Specifically, mtHtt impairs metabolic homeostasis and causes transcriptional dysregulation in adipose tissue. Adipogenic differentiation can be induced by the activation of two transcription factors: CCAAT/enhancer-binding protein alpha (CEBPα) and peroxisome proliferator-activated receptor gamma (PPARγ). These same transcription factors were found to be compromised in some tissues of Huntington's disease (HD) mouse models and in lymphocytes of HD patients. OBJECTIVE: This study investigated the adipogenic potential of mesenchymal stem cells (MSCs) derived from transgenic Huntington's disease (TgHD) minipigs expressing human mtHtt (1-548aa) containing 124 glutamines. Two differentiation conditions were used, employing PPARγ agonist rosiglitazone or indomethacin. METHODS: Bone marrow MSCs were isolated from TgHD and WT minipig siblings and compared by their cluster of differentiation using flow cytometry. Their adipogenic potential in vitro was analyzed using quantitative immunofluorescence and western blot analysis of transcription factors and adipogenic markers. RESULTS: Flow cytometry analysis did not reveal any significant difference between WT and TgHD MSCs. Nevertheless, following differentiation into adipocytes, the expression of CEBPα nuclear, PPARγ and adipogenic marker FABP4/AP2 were significantly lower in TgHD cells compared to WT cells. In addition, we proved both rosiglitazone and indomethacin to be efficient for adipogenic differentiation of porcine MSCs, with rosiglitazone showing a better adipogenic profile. CONCLUSIONS: We demonstrated a negative influence of mtHtt on adipogenic differentiation of porcine MSCs in vitro associated with compromised expression of adipogenic transcription factors.
Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague Pilsen Czech Republic
Faculty of Mechanical Engineering Czech Technical University Prague Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20006674
- 003
- CZ-PrNML
- 005
- 20201015141122.0
- 007
- ta
- 008
- 200511s2019 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3233/JHD-180303 $2 doi
- 035 __
- $a (PubMed)30584151
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Smatlikova, Petra $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic. Department of Cell Biology, Faculty of Science, Charles University in Prague, Czech Republic.
- 245 10
- $a Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells in Pig Transgenic Model Expressing Human Mutant Huntingtin / $c P. Smatlikova, S. Juhas, J. Juhasova, T. Suchy, M. Hubalek Kalbacova, Z. Ellederova, J. Motlik, J. Klima,
- 520 9_
- $a BACKGROUND: Although the highest expression of mutant huntingtin (mtHtt) was observed in the brain, its negative effects were also apparent in other tissues. Specifically, mtHtt impairs metabolic homeostasis and causes transcriptional dysregulation in adipose tissue. Adipogenic differentiation can be induced by the activation of two transcription factors: CCAAT/enhancer-binding protein alpha (CEBPα) and peroxisome proliferator-activated receptor gamma (PPARγ). These same transcription factors were found to be compromised in some tissues of Huntington's disease (HD) mouse models and in lymphocytes of HD patients. OBJECTIVE: This study investigated the adipogenic potential of mesenchymal stem cells (MSCs) derived from transgenic Huntington's disease (TgHD) minipigs expressing human mtHtt (1-548aa) containing 124 glutamines. Two differentiation conditions were used, employing PPARγ agonist rosiglitazone or indomethacin. METHODS: Bone marrow MSCs were isolated from TgHD and WT minipig siblings and compared by their cluster of differentiation using flow cytometry. Their adipogenic potential in vitro was analyzed using quantitative immunofluorescence and western blot analysis of transcription factors and adipogenic markers. RESULTS: Flow cytometry analysis did not reveal any significant difference between WT and TgHD MSCs. Nevertheless, following differentiation into adipocytes, the expression of CEBPα nuclear, PPARγ and adipogenic marker FABP4/AP2 were significantly lower in TgHD cells compared to WT cells. In addition, we proved both rosiglitazone and indomethacin to be efficient for adipogenic differentiation of porcine MSCs, with rosiglitazone showing a better adipogenic profile. CONCLUSIONS: We demonstrated a negative influence of mtHtt on adipogenic differentiation of porcine MSCs in vitro associated with compromised expression of adipogenic transcription factors.
- 650 _2
- $a tukové buňky $x cytologie $7 D017667
- 650 12
- $a adipogeneze $7 D050156
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a geneticky modifikovaná zvířata $x genetika $7 D030801
- 650 _2
- $a buňky kostní dřeně $x cytologie $7 D001854
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a Huntingtonova nemoc $x genetika $x patologie $7 D006816
- 650 _2
- $a mezenchymální kmenové buňky $x cytologie $7 D059630
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a transkripční faktory $x genetika $7 D014157
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Juhas, Stefan $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 700 1_
- $a Juhasova, Jana $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 700 1_
- $a Suchy, Tomas $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Czech Academy of Sciences, Prague, Czech Republic; Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague, Czech Republic.
- 700 1_
- $a Hubalek Kalbacova, Marie $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic; Institute of Pathological Physiology, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Ellederova, Zdenka $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 700 1_
- $a Motlik, Jan $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 700 1_
- $a Klima, Jiri $u PIGMOD Centre, Laboratory of Cell Regeneration and Plasticity, Institute of Animal Physiology and Genetics of the Czech Academy of Sciences, Libechov, Czech Republic.
- 773 0_
- $w MED00184837 $t Journal of Huntington's disease $x 1879-6400 $g Roč. 8, č. 1 (2019), s. 33-51
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30584151 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20201015141119 $b ABA008
- 999 __
- $a ok $b bmc $g 1525532 $s 1096730
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 8 $c 1 $d 33-51 $e - $i 1879-6400 $m Journal of Huntington's disease $n J Huntingtons Dis $x MED00184837
- GRA __
- $a NV15-25813A $p MZ0
- LZP __
- $a Pubmed-20200511